Back
Builders FirstSource, Inc. Vs. Arrowhead Pharmaceuticals, Inc. Industry Stock Comparison
Sell
43
BLDR
Builders FirstSource, Inc.
Last Price:
$109.82
Seasonality Move:
9.11%
Sell
50
ARWR
Arrowhead Pharmaceuticals, Inc.
Last Price:
$70.77
Seasonality Move:
20.18%
Sell
43
Builders FirstSource, Inc. (BLDR)
is a Sell
Is Builders FirstSource, Inc. a Buy, Sell or Hold?
-
The current Builders FirstSource, Inc. [BLDR] share price is $109.87. The Score for BLDR is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
BLDR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Arrowhead Pharmaceuticals, Inc. (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Arrowhead Pharmaceuticals, Inc. [ARWR] share price is $70.82. The Score for ARWR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
ARWR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BLDR Stock Price Chart
What is Builders FirstSource, Inc.'s stock price today?
-
The Builders FirstSource, Inc. share price today is $109.87The current trend is relatively stagnant and BLDR is experiencing slight selling pressure.
ARWR Stock Price Chart
What is Arrowhead Pharmaceuticals, Inc.'s stock price today?
-
The Arrowhead Pharmaceuticals, Inc. share price today is $70.82Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARWR is experiencing slight buying pressure.
BLDR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.79 | Sell |
| Relative Strength Index (14 RSI): | 50.26 | Buy |
| Chaikin Money Flow: | -408163 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (101.14 - 111.86) | Buy |
| Bollinger Bands (100): | (110.85 - 137.31) | Sell |
ARWR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.95 | Buy |
| Relative Strength Index (14 RSI): | 77.46 | Buy |
| Chaikin Money Flow: | 740828 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.92 - 62.36) | Buy |
| Bollinger Bands (100): | (20.46 - 47.52) | Buy |
BLDR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 109.94 | Sell |
| 20-day SMA: | 106.19 | Buy |
| 50-day SMA: | 114.24 | Sell |
| 200-day SMA: | 122.44 | Sell |
| 8-day EMA: | 109.03 | Buy |
| 20-day EMA: | 108.91 | Buy |
| 50-day EMA: | 113.41 | Sell |
| 200-day EMA: | 126.67 | Sell |
ARWR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 65.78 | Buy |
| 20-day SMA: | 53.22 | Buy |
| 50-day SMA: | 44.33 | Buy |
| 200-day SMA: | 24.55 | Buy |
| 8-day EMA: | 65.16 | Buy |
| 20-day EMA: | 56.66 | Buy |
| 50-day EMA: | 46.43 | Buy |
| 200-day EMA: | 30.4 | Buy |
Builders FirstSource, Inc. Earnings Growth & BLDR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.40 per share, and a decrease next year of $0.59 per share.
Arrowhead Pharmaceuticals, Inc. Earnings Growth & ARWR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.49 per share, and a decrease next year of $3.13 per share.
Builders FirstSource, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arrowhead Pharmaceuticals, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||